Advertisement

Ads Placeholder
Loading...

Lexeo Therapeutics, Inc. Common Stock

LXEO•NASDAQ
Healthcare
Biotechnology
$6.44
$0.00(0.00%)
U.S. Market opens in 17h 13m

Lexeo Therapeutics, Inc. Common Stock (LXEO) Stock Overview

Explore Lexeo Therapeutics, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap476.4M
P/E Ratio-34.19
EPS (TTM)$-1.86
ROE-0.67%
Fundamental Analysis

AI Price Forecasts

1 Month$6.96
3 Months$12.94
1 Year Target$12.58

LXEO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lexeo Therapeutics, Inc. Common Stock (LXEO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.86, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $12.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -34.19 and a market capitalization of 476.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.16%
5-Day Change
12.22%
1-Month Change
-13.58%
3-Month Change
-38.99%
6-Month Change
-21.59%
Year-to-Date (YTD) Change
-33.09%
1-Year Change
172.46%
3-Year Change
-36.02%
5-Year Change
-36.02%
All-Time (Max) Change
-36.02%

Contact Information

https://www.lexeotx.com
212-547-9879
345 Park Avenue South, New York City, NaN, 10010

Company Facts

750 Employees
IPO DateNov 3, 2023
CountryUS
Actively Trading

Frequently Asked Questions